Document Detail


Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus.
MedLine Citation:
PMID:  16436706     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment of the fully vancomycin-susceptible Staphylococcus aureus strain COL with subinhibitory concentrations of vancomycin allowed its continued growth but generated a phenotype reminiscent of some S. aureus isolates with vancomycin-intermediate S. aureus (VISA)-type resistance: the bacteria grew in multicellular clusters; electron microscopy showed inhibition of cell separation and accumulation of amorphous cell wall-like material at the bacterial surface. Titration of free vancomycin showed a gradual disappearance of the drug from the medium, which--eventually--coincided with an increase in the growth rate, burst in viable titer, and dispersal of cellular clusters. Addition of inhibitory concentrations of vancomycin to the same strain at a higher cell concentration caused a very different--antibiotic-tolerant--response: an immediate halt in growth, followed by a prolonged lag, during which there was neither a loss of viable titer or optical density nor a change in cell morphology but a gradual removal of vancomycin from the medium to the cell wall of the bacterium, from which the antibiotic could be recovered in a biologically active form. Eventually, the drug-treated culture resumed normal growth. The transient appearance of both the VISA phenotype and vancomycin tolerance could be traced to the inhibition of the autolytic system of the bacterium by vancomycin molecules attached to the cell wall, blocking the access of a staphylococcal murein hydrolase(s) to its cell wall substrate.
Authors:
Krzysztof Sieradzki; Alexander Tomasz
Related Documents :
19965966 - Real-time imaging of cellulose reorientation during cell wall expansion in arabidopsis ...
22438826 - Temporal transcriptional profiling of somatic and germ cells reveals biased lineage pri...
10788366 - Cell wall chemical composition of enterococcus faecalis in the viable but nonculturable...
804436 - Biologically active components from mycobacterial cell walls. iii. production of experi...
22020966 - Cd99 triggers upregulation of mir-9-modulated prdm1/blimp1 in hodgkin/reed-sternberg ce...
22367166 - Effects of scrophularia extracts on tumor cell proliferation, death and intravasation t...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  50     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-26     Completed Date:  2006-03-23     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  527-33     Citation Subset:  IM    
Affiliation:
The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bacteriolysis / drug effects*
Cell Wall / metabolism
Microbial Sensitivity Tests
N-Acetylmuramoyl-L-alanine Amidase / metabolism
Staphylococcus aureus / drug effects*,  metabolism
Teicoplanin / pharmacology
Vancomycin / pharmacology*
Vancomycin Resistance*
Grant Support
ID/Acronym/Agency:
2R01 AI045738/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
1404-90-6/Vancomycin; 61036-62-2/Teicoplanin; EC 3.5.1.28/N-Acetylmuramoyl-L-alanine Amidase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Discovery of FabH/FabF inhibitors from natural products.
Next Document:  Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumo...